GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Alibaba Health Information Technology Ltd (OTCPK:ALBBY) » Definitions » Intrinsic Value: Projected FCF
中文

Alibaba Health Information Technology (Alibaba Health Information Technology) Intrinsic Value: Projected FCF : $3.83 (As of Apr. 25, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Alibaba Health Information Technology Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-04-25), Alibaba Health Information Technology's Intrinsic Value: Projected FCF is $3.83. The stock price of Alibaba Health Information Technology is $6.89. Therefore, Alibaba Health Information Technology's Price-to-Intrinsic-Value-Projected-FCF of today is 1.8.

The historical rank and industry rank for Alibaba Health Information Technology's Intrinsic Value: Projected FCF or its related term are showing as below:

ALBBY' s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 1.8   Med: 35.53   Max: 190
Current: 1.8

During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Alibaba Health Information Technology was 190.00. The lowest was 1.80. And the median was 35.53.

ALBBY's Price-to-Projected-FCF is ranked worse than
66.23% of 305 companies
in the Healthcare Providers & Services industry
Industry Median: 1.29 vs ALBBY: 1.80

Alibaba Health Information Technology Intrinsic Value: Projected FCF Historical Data

The historical data trend for Alibaba Health Information Technology's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alibaba Health Information Technology Intrinsic Value: Projected FCF Chart

Alibaba Health Information Technology Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.65 3.40 3.63 3.70

Alibaba Health Information Technology Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 3.63 - 3.70 -

Competitive Comparison of Alibaba Health Information Technology's Intrinsic Value: Projected FCF

For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alibaba Health Information Technology's Price-to-Projected-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Alibaba Health Information Technology's Price-to-Projected-FCF falls into.



Alibaba Health Information Technology Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Alibaba Health Information Technology's Free Cash Flow(6 year avg) = $49.61.

Alibaba Health Information Technology's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Mar23)*0.8)/Shares Outstanding (Diluted Average)
=(14.862653310476*49.611571428571+2201.973*0.8)/677.079
=3.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alibaba Health Information Technology  (OTCPK:ALBBY) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Alibaba Health Information Technology's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=6.89/3.6907628006935
=1.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alibaba Health Information Technology Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Alibaba Health Information Technology's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Alibaba Health Information Technology (Alibaba Health Information Technology) Business Description

Traded in Other Exchanges
Address
Guanghua Road, 65/F, CITIC Tower, Building 1, No.10, Jianwai Subdistrict, Chaoyang District, Beijing, CHN
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or "Dr. Deer", although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 97% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.

Alibaba Health Information Technology (Alibaba Health Information Technology) Headlines

No Headlines